News
GRDN
33.80
-0.85%
-0.29
Press Release: Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call
Dow Jones · 1d ago
Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call
Barchart · 1d ago
Weekly Report: what happened at GRDN last week (0202-0206)?
Weekly Report · 1d ago
Weekly Report: what happened at GRDN last week (0126-0130)?
Weekly Report · 02/02 09:50
Analysts Have Conflicting Sentiments on These Healthcare Companies: Enovis (ENOV), Guardian Pharmacy Services, Inc. Class A (GRDN) and Biogen (BIIB)
TipRanks · 01/27 11:40
Weekly Report: what happened at GRDN last week (0119-0123)?
Weekly Report · 01/26 09:51
Guardian Pharmacy Services’ (GRDN) Flat 2026 Revenue Guide: Pragmatic Planning or Fading Growth Ambition?
Simply Wall St · 01/26 07:20
Weekly Report: what happened at GRDN last week (0112-0116)?
Weekly Report · 01/19 09:55
Analysts’ Top Healthcare Picks: Wave Life Sciences (WVE), Guardian Pharmacy Services, Inc. Class A (GRDN)
TipRanks · 01/14 13:10
Guardian Pharmacy Svcs Price Target Raised to $36.00/Share From $35.00 by Stephens & Co.
Dow Jones · 01/14 12:40
Guardian Pharmacy Svcs Is Maintained at Overweight by Stephens & Co.
Dow Jones · 01/14 12:40
Stephens & Co. Maintains Overweight on Guardian Pharmacy Service, Raises Price Target to $36
Benzinga · 01/14 12:30
Guardian Pharmacy price target raised to $36 from $35 at Stephens
TipRanks · 01/14 11:50
Press Release: Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook
Dow Jones · 01/13 22:00
Guardian Pharmacy Reaffirms 2025 Outlook, Issues 2026 Guidance
TipRanks · 01/13 21:53
Guardian Pharmacy expects 2026 revenue between $1.40B and $1.42B
Seeking Alpha · 01/13 21:45
Guardian Pharmacy affirms FY25 revenue view of $1.43B-$1.45B, consensus $1.44B
TipRanks · 01/13 21:35
Guardian Pharmacy sees FY26 revenue of $1.40B-$1.42B, consensus $1.45B
TipRanks · 01/13 21:35
Guardian Pharmacy down 2% at $30.65 after affirmed FY25, initial FY26 outlook
TipRanks · 01/13 21:35
Guardian Pharmacy Services Reiterates Its Previously Announced 2025 Revenue Guidance Of $1.43B To $1.45B; For 2026, Co. Expects Revenue In The Range Of $1.40B To $1.42B
Benzinga · 01/13 21:33
More
Webull provides a variety of real-time GRDN stock news. You can receive the latest news about Guardian Pharmacy Services, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About GRDN
Guardian Pharmacy Services, Inc. is a long-term care pharmacy services company. Through its locally based business model, it partners with long-term care facilities (LTCF0073) to deliver medications, and a comprehensive suite of technology-enabled services designed to enhance care and improve adherence to drug regimens, helping to reduce the cost of care and improve clinical outcomes. Through its locally based pharmacies, the Company utilizes a complex, technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle in order to manage medication risk. Its Guardian Compass platform offers insights to enhance efficiency for its pharmacies, including proprietary real-time operational dashboards and metrics. Its suite of GuardianShield products offers customer and clinical services that benefit both the residents it serves and their caregivers.